|
Name |
Sorbicillin
|
Molecular Formula | C14H16O3 | |
IUPAC Name* |
(2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
|
|
SMILES |
C/C=C/C=C/C(=O)C1=C(C(=C(C(=C1)C)O)C)O
|
|
InChI |
InChI=1S/C14H16O3/c1-4-5-6-7-12(15)11-8-9(2)13(16)10(3)14(11)17/h4-8,16-17H,1-3H3/b5-4+,7-6+
|
|
InChIKey |
RKKPUBAAIGFXOG-YTXTXJHMSA-N
|
|
Synonyms |
Sorbicillin; 79950-85-9; (2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one; 2V94TML24G; 3-Hydroxy-2,4-dimethyl-6-(1-oxo-hexa-2,4-dienyl)phenol; Osrbicilin; (2E,4E)-1-(2,4-Dihydroxy-3,5-dimethylphenyl)-2,4-hexadien-1-one; 2,4-Hexadien-1-one, 1-(2,4-dihydroxy-3,5-dimethylphenyl)-, (2E,4E)-; UNII-2V94TML24G; MEGxm0_000242; SCHEMBL3122114; CHEMBL4437946; ACon0_000046; ACon1_001459; CHEBI:167836; DTXSID601347883; ZINC5132802; NCGC00180484-01; HY-146748; CS-0438616; BRD-K91836452-001-01-3; Q27255645; (2E,4E)-1-(2,4-Dihydroxy-3,5-dimethylphenyl)-2,4-hexadien-1-one #; 2,4-Hexadien-1-one, 1-(2,4-dihydroxy-3,5-dimethylphenyl)-, (E,E)-; NCGC00180484-02!(2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
|
|
CAS | 79950-85-9 | |
PubChem CID | 5376187 | |
ChEMBL ID | CHEMBL4437946 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 232.27 | ALogp: | 3.6 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 17 | QED Weighted: | 0.473 |
Caco-2 Permeability: | -4.766 | MDCK Permeability: | 0.00002310 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.019 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.121 | Plasma Protein Binding (PPB): | 99.44% |
Volume Distribution (VD): | 0.241 | Fu: | 1.39% |
CYP1A2-inhibitor: | 0.843 | CYP1A2-substrate: | 0.932 |
CYP2C19-inhibitor: | 0.179 | CYP2C19-substrate: | 0.458 |
CYP2C9-inhibitor: | 0.115 | CYP2C9-substrate: | 0.598 |
CYP2D6-inhibitor: | 0.324 | CYP2D6-substrate: | 0.796 |
CYP3A4-inhibitor: | 0.09 | CYP3A4-substrate: | 0.278 |
Clearance (CL): | 9.194 | Half-life (T1/2): | 0.809 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.541 |
Drug-inuced Liver Injury (DILI): | 0.194 | AMES Toxicity: | 0.514 |
Rat Oral Acute Toxicity: | 0.669 | Maximum Recommended Daily Dose: | 0.946 |
Skin Sensitization: | 0.956 | Carcinogencity: | 0.547 |
Eye Corrosion: | 0.056 | Eye Irritation: | 0.931 |
Respiratory Toxicity: | 0.929 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004879 | 0.787 | D05QDC | 0.282 | ||||
ENC002528 | 0.698 | D0B1IP | 0.250 | ||||
ENC001498 | 0.592 | D0V9EN | 0.231 | ||||
ENC005051 | 0.532 | D0T3NY | 0.229 | ||||
ENC004624 | 0.509 | D05FTJ | 0.218 | ||||
ENC005052 | 0.508 | D09EBS | 0.215 | ||||
ENC002196 | 0.460 | D0L5FY | 0.212 | ||||
ENC001744 | 0.379 | D0Y7PG | 0.207 | ||||
ENC001445 | 0.368 | D0H2ZW | 0.205 | ||||
ENC005698 | 0.358 | D0J1VY | 0.198 |